← Leaderboards
Donald Abrams
University Of California San Francisco
$1,128
Attributed
$1,128
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,128 · 2
By mechanism
M01$1,128 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Morris Schambelan$4,926,809
- Marc Kopel Hellerstein$9,825,255
- Diane W. Wara$7,985,315
- Laurence H. Tecott$8,080,377
- Ann Petru$791,951
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationAppetiteClinical ResearchDrug Screening /EvaluationAids TherapyHuman SubjectDrug Adverse EffectDrug InteractionsHiv InfectionsIndinavirNutrient Intake ActivityStimulant /AgonistThalidomideAidsVirus LoadBody CompositionCachexiaCannabinoidsCannabisDosage
Grant awards (12)
COMPASSIONATE USE OF THALIDOMIDE IN ADULTS WITH HIV ASSOCIATED WASTING$0
M01 · FY2002 · RR
SHORT TERM EFFECTS OF CANNABINOIDS IN PATIENTS W/ HIV 1 INFECTION$0
M01 · FY2002 · RR
SHORT TERM EFFECTS OF CANNABINOIDS IN PATIENTS W/ HIV 1 INFECTION$0
M01 · FY2002 · RR
COMPASSIONATE USE OF THALIDOMIDE IN ADULTS WITH HIV ASSOCIATED WASTING$0
M01 · FY2002 · RR
COMPASSIONATE USE OF THALIDOMIDE IN ADULTS WITH HIV ASSOCIATED WASTING$0
M01 · FY2001 · RR
SHORT TERM EFFECTS OF CANNABINOIDS IN PATIENTS W/ HIV 1 INFECTION$0
M01 · FY2001 · RR
COMPASSIONATE USE OF THALIDOMIDE IN ADULTS WITH HIV ASSOCIATED WASTING$564
M01 · FY2000 · RR
SHORT TERM EFFECTS OF CANNABINOIDS IN PATIENTS W/ HIV 1 INFECTION$564
M01 · FY2000 · RR
COMPASSIONATE USE OF THALIDOMIDE IN ADULTS WITH HIV ASSOCIATED WASTING$0
M01 · FY2000 · RR
COMPASSIONATE USE OF THALIDOMIDE IN ADULTS WITH HIV ASSOCIATED WASTING$0
M01 · FY2000 · RR
SHORT TERM EFFECTS OF CANNABINOIDS IN PATIENTS W/ HIV 1 INFECTION$0
M01 · FY2000 · RR
SHORT TERM EFFECTS OF CANNABINOIDS IN PATIENTS W/ HIV 1 INFECTION$0
M01 · FY2000 · RR